PCR Insider profiles DNAe’s pilot programmes for Genalysis®After DNAe announces partnership with geneOnyx in the retail environment, Ben Butkus talks to them about their clinical plans
Mar 22, 2012
Genomeweb’s PCR Insider – the global news source for PCR, sample prep and nucleic acid amplification – spoke with DNA Electronics CEO Chris Toumazou and CTO Leila Shepherd about their plans for pre-clinical pilot studies.
They described the Genalysis® system and their upcoming studies in pharmacogenetics with Dr Eric Topol and colleagues at the Scripps Research Institute in San Diego, and in infectious diseases at St Mary’s Hospital in London.
View the article (full access may be restricted to genomeweb subscribers)
DNA Electronics Powering Preventative Medicine: Bio-IT World featureRead about DNA Electronics Ltd's foundation and mission of Powering Preventative Medicine in Kevin Davies' cover feature of Bio-IT World
Sep 28, 2011
DNA Electronics Ltd’s foundation and mission of Powering Preventative Medicine is featured in Kevin Davies’ cover feature. The article profiles DNAe’s business activities in licensing semiconductor DNA sequencing to Life Technologies and Roche and in the development of Genalysis®, a rapid and totally lab-free disposable test platform for personalised medicine and infection detection. The CMOS microchip-powered platform performs a DNA test using a fully electronic method which avoids the heat-blocks, dyes and optics of traditional DNA analysis equipment.
Smart Thinking About Health: Finch’s QuarterlySummer 2011, pg. 37 [ To view the article, please subscribe on their website ]
Aug 23, 2011
Medgadget: DNAe’s Point of Care device detects predisposition to drug side effectsMedgadget reports on success of a preliminary pilot study of the SNP DR device for CYP2C9 genotyping in collaboration with Imperial College and Pfizer
Jul 12, 2011
‘Dream sequence: real-time DNA testing’ in The Engineer magazineEllie Zolfagharid reports on the birth and future of semiconductor sequencing
Nov 15, 2010
Singularity Hub on DNAe’s handheld genetic testing deviceAaron Saenz talks to CEO Chris Toumazou about the development of SNP chips that gives a result in 15-30 minutes
Sep 30, 2009
DNAe in the News
DNA Electronics at CES 2012DNAe point of care device shown on stage at CES Keynote by Paul Jacobs of Qualcomm
Jan 11, 2012
Clinical Applications of Rapid, Point-of-Care GenotypingWatch Dr Eric Topol talk about the clinical applications of rapid, point-of-care genotyping using a 15-20 minute DNA test.
Dec 10, 2011
Financial Times: How to Spend It MagazineDNAe and CEO Chris Toumazou featured in Financial Times supplement about the future of cosmetics and 'cosmeceuticals'
Dec 09, 2011
WIRED: Breakthrough Medical Gadgets – The Future of Healthcare HardwareAaron Rowe rounds up the future of healthcare hardware seen at TEDMED
Nov 03, 2011
WIRED UK: The data will see you nowFeature Article by Joao Medeiros about CEO Chris Toumazou in November issue of WIRED magazine
Nov 01, 2011
The Financial Times features DNA Electronics in articleIn a full-page feature in the Financial Times, Clive Cookson profiles Professor Chris Toumazou, co-founder and CEO of DNA Electronics
Feb 06, 2008
In a full-page feature in the Financial Times, Professor Chris Toumazou, co-founder and CEO of DNA Electronics is profiled as the driving force behind the creation of the Institute of Biomedical Engineering, Imperial College London. The IBE is a world-class postgraduate research institute, with a focus on new technology commercialisation. DNA Electronics and the application of its technology in pharmacogenetic testing for predicting drug response are described alongside other spin-out companies from the IBE in Clive Cookson’s article, which appeared in print on Wednesday 6th February 2008. More details and a video interview with Prof Toumazou available online at FT.com.
DNA Electronics featured in BBC Radio 4’s FrontiersFrontiers featured technologies for personalised medicine
Nov 08, 2007
Frontiers, BBC Radio 4’s flagship science and technology programme, broadcast a feature on the medical technologies being developed and spun out from Imperial College’s Institute of Biomedical Engineering. The programme featured technologies for personalised medicine such as wireless “digital plaster” technology for continuous vital sign monitoring and DNA Electronics’ portable genetic tests to ensure that prescription drugs are matched to an individual’s genetic makeup.